annual operating expenses:
$143.09M+$88.97M(+164.38%)Summary
- As of today (June 17, 2025), MLTX annual total operating expenses is $143.09 million, with the most recent change of +$88.97 million (+164.38%) on December 31, 2024.
- MLTX annual operating expenses is now at all-time high.
Performance
MLTX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$47.48M-$2.10M(-4.23%)Summary
- As of today (June 17, 2025), MLTX quarterly total operating expenses is $47.48 million, with the most recent change of -$2.10 million (-4.23%) on March 31, 2025.
- Over the past year, MLTX quarterly operating expenses has increased by +$27.66 million (+139.58%).
- MLTX quarterly operating expenses is now -4.23% below its all-time high of $49.58 million, reached on December 31, 2024.
Performance
MLTX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MLTX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +164.4% | +139.6% |
| 3 y3 years | - | +197.9% |
| 5 y5 years | - | +45.3% |
MLTX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.4% | -4.2% | +267.2% |
| 5 y | 5-year | at high | +164.4% | -4.2% | +657.7% |
| alltime | all time | at high | +164.4% | -4.2% | +657.7% |
MLTX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $47.48M(-4.2%) |
| Dec 2024 | $143.09M(+164.4%) | $49.58M(+15.0%) |
| Sep 2024 | - | $43.11M(+41.0%) |
| Jun 2024 | - | $30.58M(+54.3%) |
| Mar 2024 | - | $19.82M(+31.9%) |
| Dec 2023 | $54.12M | $15.03M(+15.8%) |
| Sep 2023 | - | $12.98M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $13.19M(+2.0%) |
| Mar 2023 | - | $12.93M(-22.5%) |
| Dec 2022 | $65.06M | $16.70M(+13.0%) |
| Sep 2022 | - | $14.77M(-16.3%) |
| Jun 2022 | - | $17.65M(+10.7%) |
| Mar 2022 | - | $15.94M(+154.4%) |
| Sep 2021 | - | $6.27M(-80.8%) |
| Jun 2021 | - | $32.68M |
FAQ
- What is MoonLake Immunotherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual operating expenses year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly operating expenses year-on-year change?
What is MoonLake Immunotherapeutics annual total operating expenses?
The current annual operating expenses of MLTX is $143.09M
What is the all time high annual operating expenses for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total operating expenses is $143.09M
What is MoonLake Immunotherapeutics annual operating expenses year-on-year change?
Over the past year, MLTX annual total operating expenses has changed by +$88.97M (+164.38%)
What is MoonLake Immunotherapeutics quarterly total operating expenses?
The current quarterly operating expenses of MLTX is $47.48M
What is the all time high quarterly operating expenses for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total operating expenses is $49.58M
What is MoonLake Immunotherapeutics quarterly operating expenses year-on-year change?
Over the past year, MLTX quarterly total operating expenses has changed by +$27.66M (+139.58%)